| 5/23/2024 | BK | Market Commentary: McAfee, Staples, IMA, Cirque, Mariner, 84 Lumber, V2X, Intrado, Motus and many more break
|
| 5/22/2024 | BK | Market Commentary: Pactiv, Hamilton, Arclin, Energizer, Learning Care, Golden Entertainment loans break
|
| 5/22/2024 | BK | Moody's assigns B3 to PCI Pharma loan
|
| 5/22/2024 | BK | S&P rates PCI Pharma add-on B-
|
| 5/22/2024 | BK | PCI Pharma lifts term loan to $1.95 billion, sets issue price at par
|
| 5/20/2024 | BK | Market Commentary: Michael Baker, Maximum revised; Omnia, Gulfeagle, Vertiv, USI, Ryan and many more set talk
|
| 5/20/2024 | BK | PCI Pharma launches $1.94 billion term loan at SOFR plus 325 bps
|
| 1/23/2024 | BK | Market Commentary: TMF Group, PCI Pharma, Imagine Learning break; Dun & Bradstreet, DRW, Charter Next updated
|
| 1/19/2024 | BK | Market Commentary: HUB, Calpine, Crocs, Solenis, Autokiniton, Chamberlain, Cross, Warner, Kenan and more break
|
| 1/19/2024 | BK | PCI Pharma lifts term loan to $440 million, revises OID to 99.5
|
| 1/16/2024 | BK | Market Commentary: Dave & Buster’s, ArcLight GCX, Focus Financial break; Parexel, Conservice, MKS updated
|
| 1/16/2024 | BK | PCI Pharma to launch $400 million incremental term loan on Wednesday
|
| 11/9/2021 | BK | Market Commentary: Acrisure, Howden Group, Monotype, PCI Pharma break; Parts Authority, Apex revise deals
|
| 11/8/2021 | BK | Market Commentary: FR Refuel, Angus, Summit Behavioral break; PCI changes emerge; Vantage Elevator accelerated
|
| 11/8/2021 | BK | PCI Pharma shifts funds between first- and second-lien term loans
|
| 11/1/2021 | BK | Market Commentary: IntraFi Network, UST Global break; Vantage opts to place second-lien; Echo revises deadline
|
| 11/1/2021 | BK | PCI Pharma to launch $510 million incremental term loan on Tuesday
|
| 9/25/2020 | BK | Market Commentary: Hyland Software, PCI Pharma, Barrette, ASP Navigate, Closure Systems free to trade
|
| 9/24/2020 | BK | Market Commentary: Global Medical, EFS Cogen, Allegro, GCI break; PCI, ASP Navigate, Barrette, Hyland revised
|
| 9/24/2020 | BK | PCI Pharma shifts funds between first- and second-lien term loans
|
| 9/23/2020 | BK | Market Commentary: Omnitracs breaks; Ellucian, Vistra, Global Medical, GCI, Allegro, Agiliti changes emerge
|
| 9/17/2020 | BK | Market Commentary: Aveanna, Wabash, Michaels, Pactiv break; Netsmart, PCI, Barrette, Hyland, Ellucian set talk
|
| 9/17/2020 | BK | PCI Pharma launches $870 million term loan at Libor plus 375-400 bps
|
| 9/15/2020 | BK | Market Commentary: Shearer’s Foods breaks; Lightpath, Waystar, Pactiv revised; Delta, Aveanna accelerated
|
| 9/15/2020 | BK | PCI to launch $995 million first-lien credit facilities on Thursday
|
| 9/21/2018 | BK | Market Commentary: Cohu, Ciena, 8th Avenue Food, Garrett Motion, Peraton break; Restaurant Technologies tweaked
|
| 9/20/2018 | BK | Market Commentary: AkzoNobel breaks; Ciena, 8th Avenue, U.S. Lumber, Garrett, PCI Pharma revisions emerge
|
| 9/20/2018 | BK | PCI Pharma tightens $50 million incremental loan issue price to par
|
| 9/12/2018 | BK | Market Commentary: Gopher breaks; Sedgwick up on buyout announcement; Ensono, American Airlines update deals
|
| 9/12/2018 | BK | S&P affirms Pioneer UK debt
|
| 9/12/2018 | BK | PCI Pharma launches $50 million incremental term loan at 99.5 OID
|
| 6/29/2016 | BK | Market Commentary: Global Brass, PCI Pharma break; Diamond Resorts gains on buyout; Gymboree up with asset sale
|
| 6/29/2016 | BK | PCI flexes $205 million second-lien term loan to Libor plus 875 bps
|
| 6/14/2016 | BK | PCI Pharma Services shops first-and second-lien term loans
|
| 6/8/2016 | BK | Market Commentary: Life Time Fitness, Cushman, Eze Software, WME hit secondary; Vencore, West, Ennis reworked
|
| 6/8/2016 | BK | PCI Pharma readies launch of $730 million credit facility for Monday
|
| 6/1/2016 | BK | PCI Pharma plans new debt financing for purchase by Partners Group
|
